The narrative has been removed to reduce the size of the distribution of the Hl7.Fhir.Specification library
"
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-ballot-status",
"valueString": "External"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
"valueInteger": 0
}
],
"url": "http://hl7.org/fhir/v2/0477",
"identifier": {
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113883.18.304"
},
"version": "2.8.2",
"name": "v2 Controlled Substance Schedule",
"status": "active",
"experimental": false,
"publisher": "HL7, Inc",
"contact": [
{
"telecom": [
{
"system": "url",
"value": "http://hl7.org"
}
]
}
],
"description": "FHIR Value set/code system definition for HL7 v2 table 0477 ( Controlled Substance Schedule)",
"caseSensitive": false,
"valueSet": "http://hl7.org/fhir/ValueSet/v2-0477",
"content": "complete",
"concept": [
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/codesystem-comments",
"valueString": "Includes drugs that have a high potential for abuse, no currently accepted medical use in the United States and a lack of accepted safety for use under medical supervision."
}
],
"code": "I",
"display": "Schedule I"
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/codesystem-comments",
"valueString": "Includes drugs having currently accepted medical use in the United States and a high abuse potential, with severe psychological or physical dependence liability."
}
],
"code": "II",
"display": "Schedule II"
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/codesystem-comments",
"valueString": "Includes drugs having an abuse potential less than that of drugs listed in Schedules I and II. All CS III drugs have a currently accepted medical use in the United States."
}
],
"code": "III",
"display": "Schedule III"
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/codesystem-comments",
"valueString": "Includes drugs having a lesser potential for abuse than those listed in Schedule III. CS IV drugs have a currently accepted medical use in the United States."
}
],
"code": "IV",
"display": "Schedule IV"
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/codesystem-comments",
"valueString": "Includes drugs having low abuse potential and limited physical or psychological dependence relative to those listed in IV and have an accepted medical use in the United States."
}
],
"code": "V",
"display": "Schedule V"
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/codesystem-comments",
"valueString": "State defined"
}
],
"code": "VI",
"display": "Schedule VI"
}
]
}